BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Neocentromeres
,
Doxorubicin
,
rs3825942
,
PBX1
,
cell-cell adhesion
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
OBPs
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for OBPs
Explore Curated Studies Results
Literature
Most Relevant Literature
Highly sensitive and selective electrochemical biosensor using odorant-binding protein to detect ald…
The transcriptional regulator Zfat is essential for maintenance and differentiation of the adipocyte…
Identification and Functional Analysis of Odorant Binding Proteins in Apriona germari (Hope).
Structural determinants of odorant-binding proteins affecting their ability to form amyloid fibrils.
Overexpression of Two Odorant Binding Proteins Confers Chlorpyrifos Resistance in the Green Peach Ap…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Special Combination of OBP-301 and Pembrolizumab
Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in…
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer
Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With …
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocar…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ